Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL132155)
American Heart Association (18TPA34250009)
Article History
Accepted: 11 November 2020
First Online: 24 November 2020
Compliance with Ethical Standards
:
: Longhou Fang has a pending patent on Methods for the treatment of abnormal hematopoiesis and blood diseases using APOA-I binding protein.The other authors declare that they have no conflict of interest.
: All procedures performed in studies involving animals were in accordance with the ethical standards of the institution at which the studies were conducted and ethical approval was obtained from IACUC, AUP-0514-0027, and AUP-0718-0038.